Kirkland Represents Mead Johnson on Acquisition by Reckitt Benckiser for Approximately $17.9 Billion

Kirkland & Ellis LLP advised Mead Johnson Nutrition Company (NYSE: MJN), a global leader in pediatric nutrition, on its acquisition by Reckitt Benckiser Group plc (RB) (LSE: RB), the world’s leading consumer health and hygiene company, for approximately $17.9 billion including net debt. Closing of the transaction is subject to customary conditions, including approval by shareholders of both Mead Johnson and RB and regulatory approvals, and is expected to occur during the third quarter of 2017. The full release is available here.

The Kirkland team was led by corporate partners Jonathan Davis, Daniel Wolf, David Holdsworth, Willard Boothby in addition to David Fox and associates Jackson Blair, Miae Woo, Jeff Zhang, Sangbeck Kim, Michael Marcantonio, Jonathan Khoury and Anne Stroude; executive compensation partner Scott Price and associate Julia Onorato; tax partner Dean Shulman and associates Adam Kool and Vivek Ratnam; debt financing partners Daniel Borg and Neel Sachdev; antitrust and competition partners Ian John and Paula Reidel; and capital markets partner Tim Cruickshank.